Share This Article:

CD38 expression on CD8+ cells—Its influence on development of tuberculosis in HIV positive individuals

Abstract Full-Text HTML XML Download Download as PDF (Size:743KB) PP. 65-71
DOI: 10.4236/oji.2012.22008    3,655 Downloads   7,584 Views   Citations

ABSTRACT

CD38 expression on CD8+ cells seems to correlate well with HIV viral-loads, while the ex-pression levels are thought to be low in patients with tuberculosis. This study aimed at determining the levels of CD38 expression in HIV+ individuals who develop tuberculosis. Expression levels of CD8 and CD38 were analysed in peripheral blood collected from HIV (73), TB (32), HIV-TB (31) and healthy controls (20). The percentage of CD8+/CD38+ cells significantly increased during the first few years of seropositivity and decreased during 5 - 6 years. A decline in the expression of CD38, especially on CD8+ cells in a HIV+ individual within first 2 years of seropositivity, may be indicative of susceptibility to tuberculosis. This observation was reiterated when two patients developed TB during follow-up. CD38 on CD8 cells could perhaps be useful as an early biomarker for tuberculosis in HIV-positive individuals.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Sharada, R. , Rani, H. , Pydi, S. , Subbanna, J. and Valluri, V. (2012) CD38 expression on CD8+ cells—Its influence on development of tuberculosis in HIV positive individuals. Open Journal of Immunology, 2, 65-71. doi: 10.4236/oji.2012.22008.

References

[1] Giorgi, J.V., Majchrowicz, M.A., Johnson, T.D., et al. (1998) Immunologic effects of combined protease inhibitor and reverse transcriptase inhibitor therapy in previously treated chronic HIV-1 infection. AIDS, 12, 1833-1844. doi:10.1097/00002030-199814000-00015
[2] Langford, S.E., Ananworanich, J. and Cooper, D.A. (2007) Predictors of disease progression in HIV infection: A review. AIDS Research and Therapy, 4, 11. doi:10.1186/1742-6405-4-11
[3] Rodrigues, D.S.S., Cunha, R.M.C., Kallas, E.G., et al. (2003) Distribution of naive and memory/effector CD4+ T lymphocytes and expression of CD38 on CD8+ T lymphocytes in AIDS patients with tuberculosis. The Brazilian Journal of Infectious Diseases, 7, 161-165. doi:10.1590/S1413-86702003000200010
[4] Rodrigues, D.S.S., Medeiros, E.A.S., Weckx, L.Y., et al. (2002) Immunophenotyping characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease. Clinical and Experimental Immunology, 128, 149-154. doi:10.1046/j.1365-2249.2002.01809.x
[5] Dembek, C.J., Kutscher, S., Heltai, S., et al. (2010) Nefspecific CD45RA+ CD8+ T cells secreting MIP-1β but not IFN-γ are associated with nonprogressive HIV-1 infection. AIDS Research and Therapy, 7, 20. doi:10.1186/1742-6405-7-20
[6] Imami, N. and Gotch, F. (2002) Prospects for immune reconstitution in HIV-1 infection. Clinical and Experimental Immunology, 127, 402-411. doi:10.1046/j.1365-2249.2002.01822.x
[7] Benito, J.M., Lopez, M., Lozano, S., et al. (2005) Differential upregulation of CD38 on differential T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndrome, 38, 373-381. doi:10.1097/01.qai.0000153105.42455.c2
[8] Viegas, M.S., Carmo, A.D., Silva, T., et al. (2007) CD38 plays a role in effective containment of mycobacteria within granulomata and polarization of Th1 immune responses against Mycobacterium avium. Microbes and Infection, 9, 847-854. doi:10.1016/j.micinf.2007.03.003
[9] Pydi, S.S., Bandaru, A., Venkatasubramanian, S., et al. (2011) Vaccine for tuberculosis: Up-regulation of IL-15 by Ag85A and not by ESAT-6. Tuberculosis, 91, 136-139. doi:10.1016/j.tube.2010.12.003
[10] Barry, S.M., Johnson, M.A. and Janossy, G. (2003) Increased proportions of activated and proliferating memory CD8+ T lymphocytes in both blood and lung are associated with blood HIV viral load. Journal of Acquired Immune Deficiency Syndrome, 34, 351-357. doi:10.1097/00126334-200312010-00001
[11] Shepard, B.D., Loutfy, M.R., Raboud, J., et al. (2008) Early changes in T-cell activation predict antiretroviral success in salvage therapy of HIV infection. Journal of Acquired Immune Deficiency Syndrome, 48, 149-155. doi:10.1097/QAI.0b013e31816d9c3b
[12] Glencross, D.K., Janossy, G., Coetzee, L.M., et al. (2008) CD8/CD38 activation yields important clinical information of effective antiretroviral therapy: Findings from the first year of the CIPRA-SA cohort. Cytometry Part B: Clinical Cytometry, 74, 131-140. doi:10.1002/cyto.b.20391
[13] Biancotto, A., Grivel, J.C., Iglehart, S.J., et al. (2007) Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood, 109, 4272-4279. doi:10.1182/blood-2006-11-055764
[14] Zhang, Y., Nakata, K., Weiden, M. and Rom, W.N. (1995) Mycobacterium tuberculosis enhances human immunodeficiency Virus-1 replication by transcriptional activation at the long terminal repeat. Journal of Clinical Investigations, 95, 2324-2331. doi:10.1172/JCI117924
[15] Goletti, D., Weissman, D., Jackson, R.W., et al. (1996) Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. Journal of Immunology, 157, 1271-1278.
[16] Wolday, D., Tegbaru, B. ,Kassu, A., et al. (2005) Expression of chemokine receptors CCR5 and CXCR4 on CD4+ T cells and plasma chemokine levels during treatment of active tuberculosis in HIV-1-coinfected patients. Journal of Acquired Immune Deficiency Syndrome, 39, 265-271. doi:10.1097/01.qai.0000163027.47147.2e
[17] Lawn, S.D., Shattock, R.J., Acheampong, J.W., et al. (1999) Sustained plasma TNF-α; and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans. AIDS, 13, 2231-2237. doi:10.1097/00002030-199911120-00005
[18] Toossi, Z., Mayanja-Kizza, H., Hrisch, C.S., et al. (2001) Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients. Clinical and Experimental Medicine, 123, 233-238.
[19] Wolday, D., Hailu, B., Girma, M., et al. (2003) Low CD4+ T-cell count and high HIV viral load precede the development of tuberculosis disease in a cohort of HIV-positive Ethiopians. International Journal of Tuberculosis & Lung Diseases, 7, 110-116.
[20] Morris, L., Martin, D.J., Bredell, H., et al. (2003) Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African petients. Journal of Infectious Diseases, 187, 1967-1971. doi:10.1086/375346
[21] Astena, L.V., Langendama, M., Zangerleb, R., et al. (2003) Tuberculosis risk varies with the duration of HIV infection: A prospective study of European drug users with known date of HIV seroconversion. AIDS, 17, 1201-1208.

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.